Sciencast Management LP Buys 5,944 Shares of Colgate-Palmolive Company $CL

Key Points

• Sciencast Management LP increased its stake in Colgate-Palmolive by 17.7%, now owning 39,447 shares valued at approximately $3.7 million, making it the firm’s 4th largest position.
• Colgate-Palmolive's recent earnings report showed an EPS of $0.92, surpassing estimates, with a revenue increase of 1.0% year-over-year to $5.11 billion.
• Analyst ratings for Colgate-Palmolive include a variety of price adjustments, with a consensus rating of "Moderate Buy" and an average price target of $98.92.

Sciencast Management LP increased its position in Colgate-Palmolive Company (NYSE:CL - Free Report) by 17.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 39,447 shares of the company's stock after buying an additional 5,944 shares during the period. Colgate-Palmolive accounts for 0.8% of Sciencast Management LP's portfolio, making the stock its 4th largest holding. Sciencast Management LP's holdings in Colgate-Palmolive were worth $3,696,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in CL. Cornerstone Wealth Management LLC increased its position in Colgate-Palmolive by 1.2% in the first quarter. Cornerstone Wealth Management LLC now owns 9,035 shares of the company's stock worth $847,000 after purchasing an additional 110 shares during the period. Aberdeen Wealth Management LLC boosted its holdings in Colgate-Palmolive by 0.6% during the fourth quarter. Aberdeen Wealth Management LLC now owns 20,651 shares of the company's stock worth $1,877,000 after buying an additional 125 shares during the last quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO boosted its holdings in Colgate-Palmolive by 4.0% during the first quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO now owns 3,388 shares of the company's stock worth $317,000 after buying an additional 130 shares during the last quarter. Continuum Advisory LLC boosted its holdings in Colgate-Palmolive by 17.2% during the fourth quarter. Continuum Advisory LLC now owns 893 shares of the company's stock worth $81,000 after buying an additional 131 shares during the last quarter. Finally, KFG Wealth Management LLC boosted its holdings in Colgate-Palmolive by 1.5% during the first quarter. KFG Wealth Management LLC now owns 8,835 shares of the company's stock worth $828,000 after buying an additional 131 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.

Analyst Upgrades and Downgrades

CL has been the topic of a number of recent analyst reports. Morgan Stanley reduced their target price on Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. Wells Fargo & Company cut their price objective on Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating on the stock in a report on Monday, August 4th. JPMorgan Chase & Co. cut their price objective on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. UBS Group cut their price objective on Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a report on Thursday, July 17th. Finally, Citigroup cut their price objective on Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating on the stock in a report on Monday, August 4th. Seven equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $98.00.

Colgate-Palmolive Stock Down 0.8%

Colgate-Palmolive stock traded down $0.71 during midday trading on Friday, reaching $83.35. The stock had a trading volume of 3,169,120 shares, compared to its average volume of 4,484,784. The firm's fifty day simple moving average is $85.95 and its 200-day simple moving average is $89.54. Colgate-Palmolive Company has a 1-year low of $82.29 and a 1-year high of $106.26. The stock has a market capitalization of $67.37 billion, a P/E ratio of 23.41, a price-to-earnings-growth ratio of 4.37 and a beta of 0.35. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.89 by $0.03. The business had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.Colgate-Palmolive's revenue for the quarter was up 1.0% compared to the same quarter last year. During the same quarter last year, the firm earned $0.91 EPS. As a group, analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be given a dividend of $0.52 per share. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 annualized dividend and a dividend yield of 2.5%. Colgate-Palmolive's payout ratio is 58.43%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.